Literature DB >> 12439031

Pain at home in sickle cell disease: an underrecognized problem.

Winfred C Wang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439031     DOI: 10.1097/00043426-200211000-00003

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  6 in total

1.  Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use.

Authors:  Amanda M Brandow; Nancy J Wandersee; Mahua Dasgupta; Raymond G Hoffmann; Cheryl A Hillery; Cheryl L Stucky; Julie A Panepinto
Journal:  Br J Haematol       Date:  2016-08-19       Impact factor: 6.998

2.  Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization.

Authors:  Amanda M Brandow; Danielle L Jirovec; Julie A Panepinto
Journal:  Am J Hematol       Date:  2010-08       Impact factor: 10.047

3.  Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities.

Authors:  Amanda M Brandow; Julie A Panepinto
Journal:  Expert Rev Hematol       Date:  2010-06       Impact factor: 2.929

4.  Neuropathic pain in patients with sickle cell disease.

Authors:  Amanda M Brandow; Rebecca A Farley; Julie A Panepinto
Journal:  Pediatr Blood Cancer       Date:  2013-10-26       Impact factor: 3.167

5.  The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay.

Authors:  Amanda M Brandow; Rebecca A Farley; Mahua Dasgupta; Raymond G Hoffmann; Julie A Panepinto
Journal:  J Pediatr Hematol Oncol       Date:  2015-01       Impact factor: 1.289

Review 6.  Sickle cell disease: a natural model of acute and chronic pain.

Authors:  Amanda M Brandow; Katherine J Zappia; Cheryl L Stucky
Journal:  Pain       Date:  2017-04       Impact factor: 7.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.